Beam Therapeutics Inc. (BEAM) vs Inspire Medical Systems, Inc. (INSP)

A side-by-side comparison of Beam Therapeutics Inc. and Inspire Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BEAM vs INSP

growth of $100 · dividends reinvested · last 7y
BEAM +30.7% (+3.9%/yr)INSP -7.3% (-1.1%/yr)BEAM compounded faster over this window
200400600Start $100202120222023202420252026$131$93
BEAM INSP

BEAM vs INSP: by the numbers

  • •BEAM is the larger company ($2.52B vs $2.02B market cap).
  • •INSP is profitable (15.03% net margin) while BEAM runs a net loss (-54.75%).
  • •BEAM grew revenue faster over the past five years (479.04% vs 38.69% CAGR).

Metrics side by side

Valuation

MetricBEAMINSP
P/E ratioN/A15.14
Forward P/EN/A58.58
P/S ratio16.152.25
P/B ratio2.362.45
EV / EBITDAN/A26.98
FCF yieldN/A5.79%

Profitability

MetricBEAMINSP
Gross margin84.05%86.13%
Operating margin-274.57%6.02%
Net margin-54.75%15.03%
ROE-8.00%16.36%
ROIC-28.96%6.33%

Growth (annualized)

MetricBEAMINSP
Revenue CAGR (5Y)479.04%38.69%
Total return CAGR (5Y)-22.27%-21.78%

Frequently asked

Which has grown faster, BEAM or INSP?
Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus INSP at 38.69%.
Is BEAM or INSP more profitable?
INSP runs the higher net margin — BEAM at -54.75% versus INSP at 15.03%.
How have BEAM and INSP total returns compared?
Over the past 5 years, BEAM delivered -22.27% and INSP delivered -21.78% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.